While our focus since mid-March has been on COVID-19, a new FDA-approved treatment for peanut allergy has been available. On January 31st, the product Palforzia (the generic name being ‘Peanut [Arachis hypogaea] Allergen Powder—dnfp’) was approved to use if one is between the ages 4 through 17 for the first dose with a confirmed diagnosis […]